Correction: Forced randomization: the what, why, and how

BMC Med Res Methodol. 2024 Nov 20;24(1):286. doi: 10.1186/s12874-024-02407-y.

Authors

Kerstine Carter¹, Olga Kuznetsova², Volodymyr Anisimov³, Johannes Krisam⁴, Colin Scherer⁵, Yevgen Ryeznik⁶, Oleksandr Sverdlov⁷

Affiliations

¹ Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA.
² Merck & Co., Inc, Rahway, NJ, USA.
³ Amgen Ltd, London, UK.
⁴ Boehringer-Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
⁵ Rensselaer Polytechnic Institute, Troy, NY, USA.
⁶ Department of Pharmacy, Uppsala University, Uppsala, Sweden.
⁷ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. alex.sverdlov@novartis.com.

No abstract available

Publication types

Published Erratum